Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERATE: Apremilast vs Etanercept in Psoriasis
NCT01690299Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started Oct 2012; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01690299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01690299.